Title |
Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial
|
---|---|
Published in |
Frontiers in immunology, November 2021
|
DOI | 10.3389/fimmu.2021.767370 |
Pubmed ID | |
Authors |
Lorna Leal, Elvira Couto, Sonsoles Sánchez-Palomino, Núria Climent, Irene Fernández, Laia Miralles, Yolanda Romero, Tania González, Maria José Maleno, Blanca Paño, Judit Pich, Carlos Nicolau, José Maria Gatell, Montserrat Plana, Felipe García, the DCV3-RISVAC04 Study Group, Lorna Leal, Irene Fernández, Elvira Couto, Yolanda Romero, Laia Miralles, Carmen Hurtado, Núria Climent, Tania González, Maria José Maleno, Judit Pich, Laura Burunat, Joan Albert Arnaiz, Blanca Paño, Carlos Nicolau, Rafael Salvador, Elisabet Farré, Sonsoles Sánchez-Palomino, José Maria Gatell, Montserrat Plana, Felipe García, Berta Torres, Constanza Lucero, Montserrat Laguno, María Martínez-Rebollar, Ana González-Cordón, John Rojas, Alexy Inciarte, Lorena de la Mora, Josep Mallolas, Esteban Martínez, José Luis Blanco, Unai Perpiñá, Josep Canals, Raquel Martín, Florencia Echeverry, Cristina Xufré, Cristina Rovira, Marta Sala, Amparo Tricas |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 25 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 12% |
Other | 2 | 8% |
Student > Master | 2 | 8% |
Student > Bachelor | 2 | 8% |
Lecturer | 1 | 4% |
Other | 2 | 8% |
Unknown | 13 | 52% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 20% |
Philosophy | 1 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Nursing and Health Professions | 1 | 4% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Other | 2 | 8% |
Unknown | 14 | 56% |